Ginkgo Bioworks

Ginkgo Bioworks

Gingko is an online word processor, that lets you work on structure & content at the same time.

Company website
Foundation year

2008

Open date

5/9/2021

About

Ginkgo Bioworks is a biotechnology company that designs non-traditional microorganisms. The company develops, tests, and licenses microorganisms that are subsequently used in cosmetics, crop processing agents, and pharmaceuticals. Ginkgo Bioworks also provides probiotic bacteria to protect the body from dangerous infections.
_______________________________________________

Number of employees: 251-500

Headquarters location: Boston, Massachusetts, USA.

Investors

Allen & Company

Stripe, Vroom, Ginkgo Bioworks, Joby Aviation, Convoy, Turo, Blend, Vox Media, Minted, TrueCar

Baillie Gifford

Spotify, Indigo, Ginkgo Bioworks, Joby Aviation, AUTO1 Group, Carbon, Tempus, HeartFlow, Graphcore, Thumbtack

Cascade Investment

Ginkgo Bioworks, Convoy, Delos, Schrodinger, OANDA Corporation

General Atlantic

AppDynamics, Toutiao, Wish, Avant, Ginkgo Bioworks, Automation Anywhere, Chime, Box, BuzzFeed, CrowdStrike

Senator Investment Group

Ginkgo Bioworks

T. Rowe Price

Cruise, Airbnb, Rivian, Magic Leap, Vroom, Ginkgo Bioworks, Deliveroo, Pure Storage, LivingSocial, Cloudera

Viking Global Investors

Impossible Foods, Moderna Therapeutics, Ginkgo Bioworks, Adaptive Biotechnologies, Apeel Sciences, Talkdesk, Druva, Credit Karma, Color, PROCEPT BioRobotics

Y Combinator

Airbnb, DoorDash, Instacart, Stripe, Flexport, Rappi, Ginkgo Bioworks, Coinbase, Convoy, Machine Zone


2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.